At the Center for Investigational Therapeutics, body imaging is an important part of the process that determines if new cancer drugs are effective.

When patients participate in Phase I trials, imaging technology such as PET scans and MRIs show doctors if a particular drug is working to shrink or eliminate tumors.

For more information about imaging, view the Molecular Imaging website.